Werbung
Werbung

GOCO

GOCO logo

GoHealth, Inc. Class A Common Stock

2.35
USD
Gesponsert
-0.01
-0.42%
09. Jan., 12:25 UTC -5
Offen

GOCO Ergebnisberichte

Positives Überraschungsverhältnis

GOCO übertreffen die 8 der letzten 22Schätzungen.

36%

Nächster Bericht

Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$91.71M
/
-$1.14
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+168.26%
/
-90.34%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-76.43%
/
-152.05%

GoHealth, Inc. Class A Common Stock earnings per share and revenue

On 13. Nov. 2025, GOCO reported earnings of -11.80 USD per share (EPS) for Q3 25, missing the estimate of -2.06 USD, resulting in a -472.15% surprise. Revenue reached 34.19 million, compared to an expected 105.09 million, with a -67.47% difference. The market reacted with a -24.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -1.14 USD, with revenue projected to reach 91.71 million USD, implying an decrease of -90.34% EPS, and increase of 168.26% in Revenue from the last quarter.
FAQ
For Q3 2025, GoHealth, Inc. Class A Common Stock reported EPS of -$11.80, missing estimates by -472.15%, and revenue of $34.19M, -67.47% below expectations.
The stock price moved down -24.27%, changed from $3.44 before the earnings release to $2.60 the day after.
The next earning report is scheduled for 25. Feb. 2026.
Based on 8 analysts, GoHealth, Inc. Class A Common Stock is expected to report EPS of -$1.14 and revenue of $91.71M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung